Company intelligence / Profile preview

Materna Medical

Mountain View, California, United States

Ownership: Private
Development stage: Commercial

Overview

Materna Medical has commercialized the Milli vaginal dilator for vaginismus and painful sex, FDA-cleared and available over-the-counter. Its second product, Ellora™ (formerly "Materna Prep"), is in a pivotal EASE trial at over 20 top US hospitals to reduce pelvic floor injuries during labor; results from feasibility studies show up to 60% reduction in pelvic muscle damage compared to controls. The EASE study will support an FDA De Novo submission in summer 2025.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

NIH-funded pivotal studycollaborations with >20 leading US hospitals for the EASE/Ellora trialCompany-in-residence at Fogarty Innovationdeveloped out of Stanford Biodesign program

Beyond the preview

Go deeper on Materna Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Materna Medical.

Explore the full profile